Trials / Completed
CompletedNCT05802212
Effect of Metformin on Patients With Polycystic Ovary Syndrome
Effect of Metformin Intervention on Patients With Polycystic Ovary Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 77 (actual)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to understand the effect of Metformin on patients with PCOS.
Detailed description
This study aims to evaluate the effects of Metformin on reproductive endocrine and reproductive outcomes in women with PCOS, and to explore its underlying mechanisms to provide the intervention strategies for PCOS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin intervention for 12 weeks | PCOS patients were treated with metformin orally for 12 weeks, and various indicators related to fertility were observed. |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2022-06-01
- Completion
- 2023-05-01
- First posted
- 2023-04-06
- Last updated
- 2025-11-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05802212. Inclusion in this directory is not an endorsement.